News

January 13, 2026

Integra Partners and HelixVM Collaborate to Redefine DME Patient Access

TROY, MICHIGAN / ACCESS Newswire / January 6, 2026 / Integra Partners has entered a strategic partnership with HelixVM, a leader in 24/7 "visit-less" asynchronous virtual care, under its Group Purchasing Organization (GPO) offer. The partnership tackles one of the biggest challenges in the durable medical equipment prosthetics, orthotics and supplies (DMEPOS) industry-getting the documentation and medical orders required to bill for services.

May 5, 2025

HelixVM™: Randomized Clinical Trial Demonstrates Marketplace's Ability to Advance Healthcare Access with Improved Provider Capacity

New York, NY. (November 29, 2023) – HelixVM™, a virtual healthcare marketplace, showcases its ability to significantly increase physician capacity, revolutionizing the way healthcare is delivered. The pioneering marketplace platform demonstrated the capability to streamline patient-doctor interactions, leading to efficient care with providers in the study seeing clear evidence of HelixVM improving access to healthcare. The successful study examined the real-world impact of the HelixVM marketplace across three key constituencies including patients, providers, and referral partners. The trial met HelixVM’s primary endpoints, with ≥80% outcomes across: Providers identifying improvement in healthcare access Patients recognizing the significant benefit of HelixVM’s FastTrack Rx service Referral partners finding clear benefits for their business and customers The groundbreaking IRB Study was executed by HITLAB, a renowned Healthcare Innovation and Technology Lab, located at New York City. The randomized clinical study evaluated patients (N=102), partners (N=5), and providers (N=11), who were confirmed users of the marketplace platform. Dr. Nabeel Saghir, MD, a provider using input from the HelixVM marketplace platform, was able to provide care to twice as many patients. He commented, “The ability for a physician to start with a robust patient chart enables the clinician to focus on patient care exclusively.” Key findings from the BRANY IRB study (ID: 23-12-625-681) include: 1. Dramatic Increase in Provider Effectiveness and Healthcare Access: The HelixVM marketplace platform streamlined the provider consultation process with the majority (91%) of providers identifying significant improvements in access to healthcare services for patients. 2. FastTrack Rx Patent-Pending Processes Provide Significant Patient Benefit: The online platform enables patients to receive prescriptions quickly, while still following comprehensive medical protocols, a benefit recognized by (89%) of patients as a useful service. 3. HelixVM Ability to Provide Clear Benefits for Referral Partners: Partners were able to receive necessary medical orders, improve care coordination and documentation, and improve patient processing speed, patient satisfaction, and health care outcomes. 80% of partners strongly agreed this benefits their business and customer base. The study recognized that majority of patients (89%), all providers (100%), and all referral partners (100%) would choose to use HelixVM in the future. The HelixVM marketplace has proven efficacy in doubling physician capacity without additional human capital through Smart Intake, AI-integrated triage clearing, and FastTrack Rx prescriptions, that leverage patent-pending asynchronous processes. The online platform, which creates a SOAP note within a physician’s respective EMR, enables 50-75% reduction in time spent on tasks like charting, diagnosis, and treatment. The platform serves as both licensable SAAS and as a marketplace, with proprietary telehealth video functionality, multi-channel patient intake, customized screening, rigorous documentation for processing and insurance claims, RCM, and favorable economics. “We extend our thanks to HITLAB and believe this study underscores the immense value that HelixVM brings in addressing the #1 issue in health care, not having enough doctors to meet patient demand, which impacts care, access, and patient outcomes.” Said Robert Rodriguez, Founder and CEO of HelixVM. “This milestone is a testament to our commitment to revolutionizing health care delivery for providers, patients, and partners alike.” Rodriguez will present these findings at Columbia University during the HITLAB Innovators Summit 2023 on November 30, 2023. For investor or media inquiries, email csutherland@helixvm.com. Stan Kachnowski, PhD MPA, the Principal Investigator of the study, commented, “Our research demonstrates the transformative potential of the HelixVM marketplace. The ability of the HelixVM marketplace to empower physicians to serve a significantly larger patient population without compromising quality of care has a significant potential to address health care supply issues.” This study creates a springboard to scale the HelixVM marketplace, which has experienced double-digit month-over-month growth in 2023. About HelixVM HelixVM has developed a patent-pending, cloud-based, medical marketplace that leverages AI to deliver fast and seamless virtual health care. We accept most major medical insurance and operate across all 50 states to deliver a revolutionary health care experience that frees both patients and providers from the drudgery of the current health care model. HelixVM patients seamlessly receive same day treatment without a required face-to-face doctor’s visit, from their phone, while using insurance. Learn more at helixvm.com About HITLAB HITLAB is an impact-first organization that offers digital health research, teaching, and advisory services to improve health delivery around the world. At HITLAB, we believe technology and health can work together to improve the quality of health delivery and healthcare worldwide. We use rigorous research and evidence-based methods to identify the best digital health solutions for each of our partners. Learn more at hitlab.org

May 5, 2025

HelixVM™: Randomized Clinical Trial Demonstrates Marketplace's Ability to Advance Healthcare Access with Improved Provider Capacity

New York, NY. (November 29, 2023) – HelixVM™, a virtual healthcare marketplace, showcases its ability to significantly increase physician capacity, revolutionizing the way healthcare is delivered. The pioneering marketplace platform demonstrated the capability to streamline patient-doctor interactions, leading to efficient care with providers in the study seeing clear evidence of HelixVM improving access to healthcare. The successful study examined the real-world impact of the HelixVM marketplace across three key constituencies including patients, providers, and referral partners. The trial met HelixVM’s primary endpoints, with ≥80% outcomes across: Providers identifying improvement in healthcare access Patients recognizing the significant benefit of HelixVM’s FastTrack Rx service Referral partners finding clear benefits for their business and customers The groundbreaking IRB Study was executed by HITLAB, a renowned Healthcare Innovation and Technology Lab, located at New York City. The randomized clinical study evaluated patients (N=102), partners (N=5), and providers (N=11), who were confirmed users of the marketplace platform. Dr. Nabeel Saghir, MD, a provider using input from the HelixVM marketplace platform, was able to provide care to twice as many patients. He commented, “The ability for a physician to start with a robust patient chart enables the clinician to focus on patient care exclusively.” Key findings from the BRANY IRB study (ID: 23-12-625-681) include: 1. Dramatic Increase in Provider Effectiveness and Healthcare Access: The HelixVM marketplace platform streamlined the provider consultation process with the majority (91%) of providers identifying significant improvements in access to healthcare services for patients. 2. FastTrack Rx Patent-Pending Processes Provide Significant Patient Benefit: The online platform enables patients to receive prescriptions quickly, while still following comprehensive medical protocols, a benefit recognized by (89%) of patients as a useful service. 3. HelixVM Ability to Provide Clear Benefits for Referral Partners: Partners were able to receive necessary medical orders, improve care coordination and documentation, and improve patient processing speed, patient satisfaction, and health care outcomes. 80% of partners strongly agreed this benefits their business and customer base. The study recognized that majority of patients (89%), all providers (100%), and all referral partners (100%) would choose to use HelixVM in the future. The HelixVM marketplace has proven efficacy in doubling physician capacity without additional human capital through Smart Intake, AI-integrated triage clearing, and FastTrack Rx prescriptions, that leverage patent-pending asynchronous processes. The online platform, which creates a SOAP note within a physician’s respective EMR, enables 50-75% reduction in time spent on tasks like charting, diagnosis, and treatment. The platform serves as both licensable SAAS and as a marketplace, with proprietary telehealth video functionality, multi-channel patient intake, customized screening, rigorous documentation for processing and insurance claims, RCM, and favorable economics. “We extend our thanks to HITLAB and believe this study underscores the immense value that HelixVM brings in addressing the #1 issue in health care, not having enough doctors to meet patient demand, which impacts care, access, and patient outcomes.” Said Robert Rodriguez, Founder and CEO of HelixVM. “This milestone is a testament to our commitment to revolutionizing health care delivery for providers, patients, and partners alike.” Rodriguez will present these findings at Columbia University during the HITLAB Innovators Summit 2023 on November 30, 2023. For investor or media inquiries, email csutherland@helixvm.com. Stan Kachnowski, PhD MPA, the Principal Investigator of the study, commented, “Our research demonstrates the transformative potential of the HelixVM marketplace. The ability of the HelixVM marketplace to empower physicians to serve a significantly larger patient population without compromising quality of care has a significant potential to address health care supply issues.” This study creates a springboard to scale the HelixVM marketplace, which has experienced double-digit month-over-month growth in 2023. About HelixVM HelixVM has developed a patent-pending, cloud-based, medical marketplace that leverages AI to deliver fast and seamless virtual health care. We accept most major medical insurance and operate across all 50 states to deliver a revolutionary health care experience that frees both patients and providers from the drudgery of the current health care model. HelixVM patients seamlessly receive same day treatment without a required face-to-face doctor’s visit, from their phone, while using insurance. Learn more at helixvm.com About HITLAB HITLAB is an impact-first organization that offers digital health research, teaching, and advisory services to improve health delivery around the world. At HITLAB, we believe technology and health can work together to improve the quality of health delivery and healthcare worldwide. We use rigorous research and evidence-based methods to identify the best digital health solutions for each of our partners. Learn more at hitlab.org

May 3, 2025

HelixVM™ teams up with Columbia University to enhance its medical marketplace, fortifying triage clearinghouse and fast-tracking patient care

HelixVM™, a virtual health care marketplace, is partnering with HITLAB, (Healthcare Innovation and Technology Lab), located at Columbia University, to elevate medical marketplace innovation. This partnership further enhances HelixVM’s cutting-edge medical marketplace, focusing on streamlining triage clearing for healthcare providers and expediting FastTrackRx™ prescriptions for patients. The HelixVM marketplace integrates AI, providing physicians with a seamless triage-clearing process that enhances timely decision-making, patient care, and resource allocation. This includes multi-channel patient intake, catering to both in-store and remote patients. The AI-driven e-Triage clearinghouse facilitates fast track medical consultations for busy providers within their own EMR ecosystem. This leads to 50-75% reduction in time providers spend on tasks like charting, diagnosis, and treatment. This encompasses in-house or third-party claims-assignment for patients covered by insurance. Furthermore, the FastTrackRx™ prescription feature offered by HelixVM aims to empower patients with a convenient and expedited prescription process. Through this innovative solution, patients can receive necessary prescriptions promptly, enhancing their overall healthcare experience and ensuring timely access to vital medications. Robert Rodriguez, Founder and CEO of HelixVM, expressed his excitement about the collaboration, stating, “Partnering with HITLAB is a significant step forward in our mission to reshape the healthcare technology landscape. This collaboration will enable us to leverage top-tier research and innovation to provide unparalleled solutions for healthcare providers and patients alike.” Stan Kachnowski, PhD MPA, Director of HITLAB, commented, “We are thrilled to join forces with HelixVM in their journey to drive healthcare innovation forward. By combining our expertise and resources, we are confident that our partnership will yield transformative advancements in medical technology.” This partnership marks the beginning of an exciting chapter for HelixVM and HITLAB, as they work together to redefine the healthcare technology landscape and create a more efficient, patient-centered medical marketplace. About HelixVM HelixVM has developed a patent-pending, cloud-based, medical marketplace that leverages AI to deliver fast and seamless virtual health care. We accept most major medical insurance and operate across all 50 states to deliver a revolutionary health care experience that frees both patients and providers from the drudgery of the current health care model. HelixVM patients seamlessly receive same day treatment without a required face-to-face doctor’s visit, from their phone, while using insurance. Learn more at helixvm.com About HITLAB HITLAB is an impact-first organization that offers digital health research, teaching, and advisory services to improve health delivery around the world. At HITLAB, we believe technology and health can work together to improve the quality of health delivery and healthcare worldwide. We use rigorous research and evidence-based methods to identify the best digital health solutions for each of our partners. Learn more at hitlab.org

May 3, 2025

Revolutionizing Healthcare Access: Insights from HITLAB’s HelixVM User Study

There is an acute need for innovative solutions in healthcare in this day of extended patient wait times, overworked doctors, and onerous administrative procedures. Data from recent surveys show that Americans wait an average of 26 days to see a healthcare provider, and that providers themselves find it difficult to handle the enormous burden of caring for 2,500 patients, which requires an estimate of 26.7 hours of time each day. The issues are made worse by inconsistencies in procedures before and after appointments, manual processes for bringing patients onboard and providing treatment, and communication barriers that hinder patient care and compliance. Notwithstanding these obstacles, there exist prospects for enhancement, and augment healthcare accessibility, standardize protocols, and optimize workflows. HelixVM™, a virtual healthcare marketplace, tackles these pressing needs. It offers fast prescriptions and medical opinions. Its accessibile from anywhere, regardless of insurance status. It can double physician processing capacity without the need for additional ancillary staff. Its smooth interoperability with electronic medical records (EMR) permits effective patient management and cross-state collaboration while guaranteeing data security. To evaluate the real-world utility and effectiveness of the HelixVM platform, HITLAB conducted a comprehensive user study with healthcare providers, focusing on usability, acceptability, efficiency and impact on healthcare access, physician time, and productivity. The study, comprising structured interviews with 10 active users of the HelixVM platform, employed qualitative thematic and sentiment analysis, and quantitative descriptive analysis to glean in-depth insights. The results of the study were overwhelmingly positive. Providers lauded HelixVM for its role in enhancing patient access, particularly for those facing transportation barriers. The platform’s streamlined processes and user-friendly interface were widely appreciated with providers emphasizing the critical importance of data safety, bolstered by HelixVM’s robust security measures. Moreover, HelixVM was found to significantly improve efficiency in patient management and collaboration, transcending geographical boundaries. Its seamless integration with EMR garnered high praise with over 50% of providers expressing positive sentiments towards this feature. Similarly, 50% of providers viewed HelixVM as an invaluable platform for practicing asynchronous medicine, highlighting its SOAP notes’ comprehensive nature and its ability to provide a time-share marketplace for supplemental income. Key findings further highlighted HelixVM’s role in saving valuable provider time per patient and enhancing overall productivity. Ninety percent of providers agreed that HelixVM’s triage SOAP notes were instrumental in saving time, while half of respondents expressed full confidence in leveraging AI decision support for improving patient-provider interactions and medical triage. In addition to these findings, providers gave suggestions to further optimize HelixVM’s capabilities. These included improving triage with AI for better clearing, addressing patient concerns, optimizing orders, and preventing incomplete patient charts. Furthermore, there were suggestions to streamline documentation for accuracy, covering medical history, medications, allergies, and patient-reported data. The user study conducted by HITLAB underlines the promise of HelixVM in tackling urgent healthcare issues. With its focus on accessibility, streamlined processes, and provider empowerment, HelixVM is a paradigm shift toward a more effective and patient-centered healthcare ecosystem. Digital health solutions such as HelixVM are rays of hope that point the way towards a healthier and more accessible future as we navigate the complexities of contemporary healthcare. About HelixVM HelixVM has developed a patent-pending, cloud-based, medical marketplace that leverages AI to deliver fast and seamless virtual health care. We accept most major medical insurance and operate across all 50 states to deliver a revolutionary health care experience that frees both patients and providers from the drudgery of the current health care model. HelixVM patients seamlessly receive same day treatment without a required face-to-face doctor’s visit, from their phone, while using insurance. Learn more at helixvm.com About HITLAB HITLAB is an impact-first organization that offers digital health research, teaching, and advisory services to improve health delivery around the world. At HITLAB, we believe technology and health can work together to improve the quality of health delivery and healthcare worldwide. We use rigorous research and evidence-based methods to identify the best digital health solutions for each of our partners. Learn more at hitlab.org